2 years ago
NVAX
AnalystsAlec StranahanAlec Stranahan's Stock Forecasts
AnalystsAlec Stranahan
Analyst Ranking
Bottom 1%
#5541 out of 5550 analysts
Average Return
-35.51%
Win Rate
29%12 out of 41
Risk vs Reward
Poor
Good
Alec Stranahan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Krystal Biotech IncKRYS | +123.21% | $151.90 | $339.06 | 2025-07-22 - 2026-07-21 | Strong Buy |
Turning Point Therapeutics IncTPTX | +106.89% | $36.74 | $76.01 | 2022-05-20 - 2022-08-16 | Strong Buy |
Novavax IncNVAX | +86.62% | $53.42 | $7.15 | 2022-05-20 - 2023-05-19 | Sell |
Krystal Biotech IncKRYS | +66.42% | $190.23 | $316.58 | 2025-10-17 - 2026-10-16 | Strong Buy |
Revolution Medicines IncRVMD | +55.46% | $28.38 | $44.12 | 2024-01-05 - 2025-01-03 | Strong Buy |
Alec Stranahan Analyst Color
Get additional color on Alec Stranahan's coverage of popular stocks
2 years ago
NVAX
Alec Stranahan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xencor IncXNCR | 3 | Hold | $26.00 | -12.81% | Maintains | a month ago |
Krystal Biotech IncKRYS | 8 | Strong Buy | $400.00 | +20.38% | Maintains | a month ago |
Agios Pharmaceuticals IncAGIO | 2 | Strong Buy | $50.00 | +63.67% | Maintains | a month ago |
Revolution Medicines IncRVMD | 4 | Strong Buy | $265.00 | +38.52% | Maintains | a month ago |
Candel Therapeutics IncCADL | 4 | Strong Buy | $18.00 | +116.09% | Upgrades | a month ago |
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $8.00 | +475.54% | Initiates Coverage On | 2 months ago |
Caribou Biosciences IncCRBU | 2 | Strong Buy | $5.00 | +1,082.03% | Maintains | 3 months ago |
Erasca IncERAS | 6 | Hold | $20.00 | +39.37% | Maintains | 3 months ago |
Perspective Therapeutics IncCATX | 3 | Hold | $5.00 | +334.78% | Maintains | 3 months ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $47.00 | +72.60% | Reiterates | 4 months ago |
Hutchmed LtdHCM | 1 | Strong Buy | $17.00 | +29.28% | Maintains | 4 months ago |
Tg Therapeutics IncTGTX | 3 | Sell | $20.00 | -67.31% | Maintains | 4 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $35.00 | +388.15% | Initiates Coverage On | 5 months ago |
Wave Life Sciences IncWVE | 1 | Strong Buy | $21.00 | +484.96% | Maintains | 7 months ago |
Novavax IncNVAX | 5 | Sell | $7.00 | N/A | Downgrades | a year ago |
Y Mabs Therapeutics IncYMAB | 5 | Hold | $12.00 | N/A | Maintains | 2 years ago |
Day One Biopharmaceuticals IncDAWN | 5 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Hookipa Pharma IncHOOK | 1 | Sell | $5.00 | N/A | Downgrades | 4 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Turning Point Therapeutics IncTPTX | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.